Guided Therapeutics (GTHP) EPS (Diluted) (QoQ) (2015 - 2025)
Guided Therapeutics (GTHP) EPS (Diluted) (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.01 Bn | 175.72 Bn | 6.27 Bn |
| 2 | Stryker | 128.76 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.96 Bn | 44.29 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.29 Bn | 26.01 Bn | 1.98 Bn |
| 7 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.44 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.72% |
| Sep 30, 2025 | 11.49% |
| Jun 30, 2025 | -60.15% |
| Mar 31, 2025 | 44.46% |
| Dec 31, 2024 | -0.63% |
| Sep 30, 2024 | 10.39% |
| Jun 30, 2024 | 99.83% |
| Mar 31, 2024 | -87,714.43% |
| Dec 31, 2023 | 34.15% |
| Sep 30, 2023 | 55.74% |
| Jun 30, 2023 | -60.10% |
| Mar 31, 2023 | 65.59% |
| Dec 31, 2022 | -88.78% |
| Sep 30, 2022 | 20.85% |
| Jun 30, 2022 | 25.04% |
| Mar 31, 2022 | -34.05% |
| Dec 31, 2021 | -901.02% |
| Sep 30, 2021 | 95.64% |
| Jun 30, 2021 | 99.80% |
| Mar 31, 2021 | -122.07% |